Psychiatr. praxi. 2025;26(2):75-82 | DOI: 10.36290/psy.2025.014

Generalized anxiety disorder and its treatment

MUDr. Katarína Adamcová1, MUDr. Pavla Stopková, Ph.D.1, 2, Mgr. Markéta Jablonská1, Mgr. David Jakeš1, 3, Barbora Darmová1, 3, Mgr. et Mgr. Iveta Fajnerová, Ph.D.1, 2
1 Národní ústav duševního zdraví, Klecany
2 3. lékařská fakulta Univerzity Karlovy, Praha
3 1. lékařská fakulta Univerzity Karlovy, Praha

Generalized Anxiety Disorder (GAD) is characterized by chronic and excessive worries across various aspects of daily life, including personal and work-related responsibilities, health, and interpersonal relationships. The diagnostic criteria undergo a slight modification with the transition from the 10th edition of the International classification of diseases (ICD-10) to the new version, ICD-11. This article examines the changes in the new classification, which is expected to become the diagnostic guideline in the coming years. The aim of this article is to explore in detail the characteristics of generalized anxiety disorder, its diagnostic challenges, and current treatment approaches, including the most modern techniques. GAD treatment typically involves pharmacotherapy, psychotherapy, or a combination of both. Common complications in the successful treatment of GAD include side effects of medications or insufficient response to treatment, including resistance. A promising approach for patients may be the use of modern technologies in the treatment of generalized anxiety disorder, such as virtual reality used at our Virtual reality research center for mental health and neurosciences at the National institute of mental health in the treatment of anxiety disorders, including GAD.

Keywords: generalized anxiety disorder, mental disease classification, pharmacotherapy, psychotherapy, virtual reality.

Accepted: June 9, 2025; Published: July 4, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adamcová K, Stopková P, Jablonská M, Jakeš D, Darmová B, Fajnerová I. Generalized anxiety disorder and its treatment. Psychiatr. praxi. 2025;26(2):75-82. doi: 10.36290/psy.2025.014.
Download citation
PDF will be unlocked 4.7.2026

References

  1. . Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. The Lancet. 2019; 393(10173):768-777. doi.org/10.1016/S0140-6736(18)31793-8. Go to original source... Go to PubMed...
  2. . Gottschalk MG, Domschke K. Genetics of generalized anxiety disorder and related traits. Dialogues in Clinical Neuroscience. 2017;19(2):159-168. Go to original source... Go to PubMed...
  3. . American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). 2013. Go to original source...
  4. . Bandelow B, Boerner JR, Kasper S, et al. The diagnosis and treatment of generalized anxiety disorder. Deutsches Arzteblatt international. 2013;110(17):300-310. doi.org/10.3238/arztebl.2013.0300. Go to original source... Go to PubMed...
  5. . World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-10). Geneva: WHO. 1992.
  6. . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: APA. 1994.
  7. . Hofmann SG, Asnaani A, Vonk IJJ, et al. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses. Cognitive Therapy and Research. 2012;36(5):427-440. Go to original source... Go to PubMed...
  8. . World Health Organization. International Classification of Diseases 11th Revision (ICD-11). ICD-11. 2019.
  9. . Spitzer RL, Kroenke K, Williams JBW, et al. Brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine. 2006;166(10):1092-1097. doi.org/10.1001/archinte.166. 10. 1092; do českého jazyka zpracováno leden 2012. RBTLYR-11-236. Go to original source... Go to PubMed...
  10. . Maier W, Buller R, Philipp M, et al. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. Journal of Affective Disorders. 1988;14(1):61-68. doi.org/10.1016/0165- 0327(88)90072-9. Go to original source... Go to PubMed...
  11. . Nosková E, Šebela A, Stopková P. Aktuální trendy v léčbě generalizované úzkostné poruchy. Psychiatr. praxi. 2020;21(2):66-72. Go to original source...
  12. . Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic re­view and network meta‑analysis. 2019. The Lancet. 393(10173):768-777. doi.org/10.1016/S0140-6736(18)31793-8. Go to original source... Go to PubMed...
  13. . Guaiana G, Barbui C, Churchill R, et al. Hydroxyzine for ge­neralised anxiety disorder. Cochrane Database of Syste­matic Reviews. 2007(4). doi.org/10.1002/14651858.CD006815 Go to original source...
  14. . Strawn JR, Geracioti TD Jr. The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic. Neuropsychiatr Dis Treat. 2007 Apr;3(2):237-43. doi: 10.2147/nedt.2007. 3. 2.237. PMID: 19300556; PMCID: PMC2654629. Go to original source...
  15. . Pande AC, Crockatt JG, Feltner DE, et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry. 2003 Mar;160(3):533-40. doi: 10.1176/appi.ajp.160. 3. 533. PMID: 12611835. Go to original source...
  16. . Generoso MB, Trevizol AP, Kasper S, et al. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis. Int Clin Psychopharmacol. 2017 Jan;32(1):49-55. doi: 10.1097/YIC.0000000000000147. PMID: 27643884. Go to original source... Go to PubMed...
  17. . Schjerning O, Rosenzweig M, Pottegård A, et al. Abuse Potential of Pregabalin: A Systematic Review. CNS Drugs. 2016 Jan;30(1):9-25. doi: 10.1007/s40263-015-0303-6. PMID: 26767525. Go to original source... Go to PubMed...
  18. . Buoli M, Grassi S, Serati M, et al. Agomelatine for the tre­atment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy. 2017;18(13):1373-1379. https://doi.org/1 0.1080/14656566.2017.1359257. Go to original source... Go to PubMed...
  19. . Strawn JR, Geracioti L, Rajdev N, et al. Pharmacotherapy for generalized anxiety disorder in adult and pediatric pati­ents: an evidence‑based treatment review. Expert Opinion on Pharmacotherapy. 2018;19(10):1057-1070. doi.or g/10.1080/14656566.2018.1491966. Go to original source... Go to PubMed...
  20. . Maneeton N, Maneeton B, Woottiluk P, et al. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: A systematic review and meta‑analysis of randomized controlled trials. Drug Design, Development and Therapy. 2016; 10:259-276. Go to original source... Go to PubMed...
  21. . Henley DV, Lipson N, Korach KS, et al. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007 Feb 1;356(5):479-85. doi: 10.1056/NEJMoa064725. PMID: 17267908. Go to original source... Go to PubMed...
  22. . Sarris J, Byrne GJ, Bousman CA, et al. Kava for generalised anxiety disorder: A 16-week double‑blind, randomised, placebo‑controlled study. Australian and New Zealand Journal of Psychiatry. 2020;54(3):288-297. https://doi.org/10.1177/0004867419891246. Go to original source... Go to PubMed...
  23. . Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders. World J Biol Psychiatry. 2023 Feb;24(2):79-117. doi: 10.1080/15622975.2022.2086295. Epub 2022 Jul 28. PMID: 35900161. Go to original source... Go to PubMed...
  24. . Garakani A, Murrough JW, Freire RC, et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry. 2020 Dec 23;11:595584. doi: 10.3389/fpsyt.2020.595584. PMID: 33424664; PMCID: PMC7786299. Go to original source... Go to PubMed...
  25. . Christensen MC, Schmidt S, Grande I. Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study. J Psychopharmacol. 2022 May;36(5):566-577. doi: 10.1177/02698811221090627. Epub 2022 May 2. PMID: 35499104; PMCID: PMC9112621. Go to original source... Go to PubMed...
  26. . Feulner L, Sermchaiwong T, Rodland N, et al. Efficacy and Safety of Psychedelics in Treating Anxiety Disorders. Ochsner J. 2023 Winter;23(4):315-328. doi: 10.31486/toj.23.0076. PMID: 38143548; PMCID: PMC10741816. Go to original source... Go to PubMed...
  27. . Fuentes JJ, Fonseca F, Elices M, et al. Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials. Front Psychiatry. 2020 Jan 21;10:943. doi: 10.3389/fpsyt.2019.00943. PMID: 32038315; PMCID: PMC6985449. Go to original source... Go to PubMed...
  28. . Fagan HA, Baldwin DS. Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions. Expert Rev Neurother. 2023 Jun;23(6):535-548. doi: 10.1080/14737175.2023.2211767. Epub 2023 May 15. PMID: 37183813. Go to original source... Go to PubMed...
  29. . Parikh TK, Strawn JR, Walkup JT, et al. Repetitive Transcranial Magnetic Stimulation for Generalized Anxiety Disorder: A Systematic Literature Review and Meta-Analysis. Int J Neuropsychopharmacol. 2022 Feb 11;25(2):144-146. doi: 10.1093/ijnp/pyab077. Go to original source... Go to PubMed...
  30. . Qi L, Wang S, Li X, et al. Non-invasive brain stimulation in the treatment of generalized anxiety disorder: A systematic review and meta-analysis. J Psychiatr Res. 2024 Oct;178:378-387. doi: 10.1016/j.jpsychires.2024. 07. 046. Epub 2024 Jul 31. Go to original source...
  31. . Covin R, Ouimet AJ, Seeds PM, et al. A meta-analysis of CBT for pathological worry among clients with GAD. Journal of anxiety disorders. 2008;22(1):108-116. Go to original source... Go to PubMed...
  32. . Papola D, Miguel C, Mazzaglia M, et al. Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. JAMA Psychiatry. 2024;81(3):250-259. doi:10.1001/jamapsychiatry.2023.3971. Go to original source... Go to PubMed...
  33. . Grieger F, Klapperich H, Hassenzahl M. Trash It, Punch It, Burn It- Using Virtual Reality to Support Coping with Negative Thoughts. In Extended Abstracts of the 2021 CHI Conference on Human Factors in Computing Systems (s.1-6). Yokohama, Japan. 2021. doi.org/10.1145/3411763.3451738 Go to original source...
  34. . Prudenzi A, Rooney B, Presti G, et al. Testing the effectiveness of virtual reality as a defusion technique for coping with unwanted thoughts. Virtual Reality. 2019;23(2): 179-185. doi.org/10.1007/s10055-018-0372-1. Go to original source...
  35. . Larsson A, Hooper N, Osborne LA, et al. Using brief cognitive restructuring and cognitive defusion techniques to cope with negative thoughts. Behavior Modification. 2016;40(3):452-482. doi.org/10.1177/0145445515621488. Go to original source... Go to PubMed...
  36. . Borkovec TD, Wilkinson L, Folensbee R, et al. Stimulus control applications to the treatment of worry. Behaviour research and therapy. 1983;21(3):247-251. doi.org/10.1016/0005-7967(83)90206-1. Go to original source... Go to PubMed...
  37. . Szkodny LE, Newman MG, Goldfried MR. Clinical experiences in conducting empirically supported treatments for generalized anxiety disorder. Behavior Therapy. 2014; 45(1): 7-20. doi.org/10.1016/j.beth.2013. 09. 009. Go to original source... Go to PubMed...
  38. . Dippel A, Brosschot JF, Verkuil B. Effects of worry postponement on daily worry: a meta-analysis. Preprints. 2022. doi.org/10.31219/osf.io/qkvhu. Go to original source...
  39. . Williams M, Honan C, Skromanis S, et al. Psychological outcomes and mechanisms of mindfulness-based training for generalised anxiety disorder: A systematic review and meta-analysis. Current Psychology. 2024;43(6):5318-5340. Go to original source... Go to PubMed...
  40. . Andoni M, Vaida S. Treatment of Generalized Anxiety Disorder with Virtual Reality. Systematic Review. Educatia. 2024;21(29).
  41. . Eilert N, Enrique A, Wogan R, et al. The effectiveness of Internet-delivered treatment for generalized anxiety disorder: An updated systematic review and meta-analysis. Depression and Anxiety. 2021;38(2):196-219. Go to original source... Go to PubMed...
  42. . Saramago P, Gega L, Marshall D, et al. Digital interventions for generalized anxiety disorder (GAD): systematic review and network meta-analysis. Frontiers in psychiatry. 2021;12:726222. Go to original source... Go to PubMed...
  43. . Dugas MJ, Freeston MH, Ladouceur R, et al. Worry themes in primary GAD, secondary GAD, and other anxiety disorders. J Anxiety Disord. 1998 May-Jun;12(3):253-61. doi: 10.1016/s0887-6185(98)00013-9. Go to original source... Go to PubMed...
  44. . Donnelly MR, Reinberg R, Ito KL, et al. Virtual Reality for the Treatment of Anxiety Disorders: A Scoping Review. Am J Occup Ther. 2021 Nov 1;75(6):7506205040. doi: 10.5014/ajot.2021.046169. Go to original source... Go to PubMed...
  45. . Keshavarz N, Abad TH, Beyrami M, et al. Efficacy of Virtual Reality Based Worry Exposure Therapy on the Anxiety Severity and Worry in Generalized Anxiety Disorder. Advances in Biosciences & Clinical Medicine. 2021;9(2):21-26. doi.org/10.7575/aiac.abcmed.v.9n.2p.21. Go to original source...
  46. . Guitard T, Bouchard S, Bélanger C, et al. Exposure to a Standardized Catastrophic Scenario in Virtual Reality or a Personalized Scenario in Imagination for Generalized Anxiety Disorder. J Clin Med. 2019 Mar 5;8(3):309. doi: 10.3390/jcm8030309. Go to original source... Go to PubMed...
  47. . Prudenzi A, Rooney B, Presti G, et al. Testing the effectiveness of virtual reality as a defusion technique for coping with unwanted thoughts. Virtual Reality. 2019;23(2):179-185. doi.org/10.1007/s10055-018-0372-1. Go to original source...
  48. . Francová A, Stopková P, Darmová B, et al. Virtual Dark Room for Exposure to Intrusive Thoughts. In Gamito P, Brown D, Koenig S, (Eds.) Proceedings of the 13th International Conference on Disability, Virtual Reality and Associated Technologies (ICDVRAT 2021). ICDVRAT http://studio.hei-lab.ulusofona.pt/archive/2021/ICDVRAT2021_Full_Proceedings_13thConf_FinalVersion.pdf
  49. . BOSS DI. Využití virtuální reality v terapeutických technikách práce s vtíravými myšlenkami u pacientů s úzkostnými poruchami. Diplomová práce. Iveta Hocko Fajnerová (vedoucí práce). Praha: Univerzita Karlova, Pedagogická fakulta. 2022. Dostupné z: Digitální depozitář Univerzity Karlovy. https://dspace.cuni.cz/handle/20.500.11956/180090.
  50. . Navarro-Haro MV, Modrego-Alarcón M, Hoffman HG, et al. Evaluation of a mindfulness-based intervention with and without virtual reality dialectical behavior therapy® mindfulness skills training for the treatment of generalized anxiety disorder in primary care: a pilot study. Frontiers in psychology. 2019;10:55. Go to original source... Go to PubMed...
  51. . Francová A, Šouláková B, Procházková L. Dechový trénink ve virtuální realitě na podporu relaxace-pilotní studie. Česká a Slovenská. 2019.
  52. . Andoni M, Vaida S. Treatment of generalized anxiety disorder with virtual reality. Systematic review. Educatia. 2024;21(29): 64-76. Go to original source...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.